Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CFAP61 antisense RNA 1 (CFAP61-AS1) is a long non-coding RNA transcribed from the antisense strand of the CFAP61 locus[3]. Antisense lncRNAs in general can regulate the expression of their sense gene partners through various mechanisms, such as RNA-RNA duplex formation, modulation of chromatin state, or interference with transcription, but specific molecular functions or clinical relevance for CFAP61-AS1 remain uncharacterized in the scientific literature as of September 2025[3][2]. There is no evidence that CFAP61-AS1 is currently considered a disease biomarker or therapeutic target. The CFAP61 gene encodes a protein essential for normal sperm flagellar structure and function; mutations in CFAP61 cause MMAF and male infertility[1]. However, this is distinct from its antisense RNA, CFAP61-AS1, which does not encode a protein[3]. Antisense lncRNAs are known to participate in diverse regulatory roles, but for many individual lncRNAs, including CFAP61-AS1, there is no detailed functional or disease-association evidence available[2][3]. No reports exist of interacting drugs or therapeutic interventions targeting CFAP61-AS1, nor is it listed as a biomarker or implicated in safety concerns to date[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CFAP61 antisense RNA 1 (CFAP61-AS1).